treatment approaches

Substance Use Disorders: Psychoneuroimmunological Mechanisms and New Targets for Therapy.

Published May 3, 2013

Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy.

Pharmacol Ther. 2013 Apr 27;
Loftis JM, Huckans M

An estimated 76.4 million people worldwide meet criteria for alcohol use disorders, and 15.3 million meet criteria for drug use… Continue reading →

Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in P53-Dependent or -Independent Manners.

Published April 27, 2013

Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners.

PLoS One. 2013; 8(4): e61537
Sarfstein R, Friedman Y, Attias-Geva Z, Fishman A, Bruchim I, Werner H… Continue reading →

[The Concept of Behavioral Addiction and Limits of the Term Addiction.]

Published April 23, 2013

[The concept of behavioral addiction and limits of the term addiction.]

Nervenarzt. 2013 Apr 21;
Mann K, Fauth-Bühler M, Seiferth N, Heinz A,

The numbers of persons with a prevalence for behavioral addiction are rising especially among the young.… Continue reading →

Crayfish-Related Haff Disease Rhabdomyolysis; Diagnosis Supported by Bone Scintigraphy.

Published April 10, 2013

Crayfish-related Haff disease rhabdomyolysis; diagnosis supported by bone scintigraphy.

Hell J Nucl Med. 2013 Jan-Apr; 16(1): 60-1
Xie P, Hu J, Huang JM, Liu XM

A number of people suffered rhabdomyolysis caused by eating crayfish in China and the… Continue reading →

Drug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA.

Published April 3, 2013

Drug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA.

Drug Deliv Transl Res. 2013 Apr 1; 3(2): 183-194
Lu S, Labhasetwar V

Cancer stem cell (CSC) population in solid human… Continue reading →

5-Fluorouracil Potentiates the Anti-Cancer Effect of Oxaliplatin on Colo320 Colorectal Adenocarcinoma Cells.

Published March 30, 2013

5-Fluorouracil potentiates the anti-cancer effect of oxaliplatin on Colo320 colorectal adenocarcinoma cells.

J Gastrointestin Liver Dis. 2013 Mar; 22(1): 37-43
Berindan-Neagoe I, Braicu C, Pileczki V, Cojocneanu Petric R, Miron N, Balacescu O, Iancu D, Ciuleanu T

BACKGROUND &… Continue reading →

L-Dopa Gains Psychostimulant-Like Properties After Nigral Dopaminergic Loss.

Published March 16, 2013

L-dopa gains psychostimulant-like properties after nigral dopaminergic loss.

Ann Neurol. 2013 Mar 12;
Engeln M, Fasano S, Ahmed SH, Cador M, Baekelandt V, Bezard E, Fernagut PO

Dopamine Dysregulation Syndrome shares some core behavioral features of psychostimulant addiction, suggesting… Continue reading →

Anatomical Correlates of Recovery in Single Pellet Reaching in Spinal Cord Injured Rats.

Published March 9, 2013

Anatomical correlates of recovery in single pellet reaching in spinal cord injured rats.

Exp Neurol. 2013 Mar 4;
Hurd C, Weishaupt N, Fouad K

Modeling spinal cord injury (SCI) in animals is challenging because an appropriate combination of lesion… Continue reading →

Cognitive-Behavioral Therapy for Body Dysmorphic Disorder: A Review of Its Efficacy.

Published March 8, 2013

Cognitive-behavioral therapy for body dysmorphic disorder: a review of its efficacy.

Neuropsychiatr Dis Treat. 2013; 9: 307-16
Prazeres AM, Nascimento AL, Fontenelle LF

The aim of this study was to review the efficacy of different methods of cognitive and/or… Continue reading →

COMT Val158Met Modulates Subjective Responses to Intravenous Nicotine and Cognitive Performance in Abstinent Smokers.

Published March 6, 2013

COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers.

Pharmacogenomics J. 2013 Mar 5;
Herman AI, Jatlow PI, Gelernter J, Listman JB, Sofuoglu M

The catechol-O-methyltransferase (COMT) Val158Met polymorphism may be a risk factor… Continue reading →